Inventor · disambiguated record
Rene Braeckman
Also filed as: BRAECKMAN RENE
88 granted patents·62 pending applications·3,643 citations·filing 2010–2025
99Inventor score
Files withAMARIN PHARMACEUTICALS IE LTD123MANKU MEHAR18OSTERLOH IAN5AMARIN PHARMA INC1AMARIN PHARMACEUTICALS IRELAND LIMITE1
Top patents by PatentIndex Score
150 records- 0199US11285127B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Mar 29, 2022·8 cites·17 claims
- 0299US11213504B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Jan 4, 2022·16 cites·11 claims
- 0399US11179362B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Nov 23, 2021·15 cites·20 claims
- 0499US11154526B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Oct 26, 2021·18 cites·6 claims
- 0599US10973797B2Methods of reducing apolipoprotein c-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Apr 13, 2021·9 cites·20 claims
- 0699US10842766B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Nov 24, 2020·11 cites·5 claims
- 0799US10792267B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Oct 6, 2020·11 cites·13 claims
- 0899US10220013B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Granted Mar 5, 2019·53 cites·20 claims
- 0999US10166209B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Granted Jan 1, 2019·64 cites·7 claims
- 1099US9855237B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Granted Jan 2, 2018·78 cites·3 claims
- 1199US9138415B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Sep 22, 2015·63 cites·17 claims
- 1299US8709475B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Apr 29, 2014·101 cites·12 claims
- 1399US8703185B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Apr 22, 2014·102 cites·12 claims
- 1499US8691871B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Apr 8, 2014·116 cites·14 claims
- 1599US8680144B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Mar 25, 2014·102 cites·14 claims
- 1699US8669245B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Mar 11, 2014·105 cites·13 claims
- 1799US8642077B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Feb 4, 2014·106 cites·19 claims
- 1899US8623406B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Jan 7, 2014·109 cites·10 claims
- 1999US8617593B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Dec 31, 2013·112 cites·20 claims
- 2099US8617594B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Dec 31, 2013·113 cites·26 claims
- 2199US8563608B2Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyMANKU MEHAR·Filed 2012·Granted Oct 22, 2013·129 cites·9 claims
- 2299US8551521B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Oct 8, 2013·108 cites·8 claims
- 2399US8546372B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Oct 1, 2013·105 cites·25 claims
- 2499US8524698B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Sep 3, 2013·105 cites·8 claims
- 2599US8518929B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Aug 27, 2013·104 cites·9 claims
- 2699US8455472B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyOSTERLOH IAN·Filed 2010·Granted Jun 4, 2013·85 cites·19 claims
- 2799US8431560B1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Apr 30, 2013·104 cites·20 claims
- 2899US8410086B2Compositions and methods for lowering triglyceridesOSTERLOH IAN·Filed 2011·Granted Apr 2, 2013·84 cites·13 claims
- 2999US8377920B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Feb 19, 2013·126 cites·10 claims
- 3099US8367652B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Feb 5, 2013·128 cites·18 claims
- 3199US8357677B1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Jan 22, 2013·128 cites·9 claims
- 3299US8324195B2Methods of treating hypertriglyceridemiaMANKU MEHAR·Filed 2012·Granted Dec 4, 2012·125 cites·14 claims
- 3399US8318715B2Methods of treating hypertriglyceridemiaMANKU MEHAR·Filed 2011·Granted Nov 27, 2012·130 cites·19 claims
- 3499US8314086B2Methods of treating hypertriglyceridemiaMANKU MEHAR·Filed 2011·Granted Nov 20, 2012·128 cites·12 claims
- 3599US8293728B2Methods of treating hypertriglyceridemiaMANKU MEHAR·Filed 2012·Granted Oct 23, 2012·140 cites·19 claims
- 3699US8293727B2Methods of treating hypertriglyceridemiaMANKU MEHAR·Filed 2010·Granted Oct 23, 2012·140 cites·17 claims
- 3798US11185525B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Nov 30, 2021·9 cites·24 claims
- 3898US11103477B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Aug 31, 2021·3 cites·7 claims
- 3998US11033523B2Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the sameMANKU MEHAR·Filed 2010·Granted Jun 15, 2021·18 cites·4 claims
- 4098US10987331B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Apr 27, 2021·7 cites·4 claims
- 4198US10881632B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Jan 5, 2021·5 cites·9 claims
- 4298US10842768B2Compositions and methods for lowering triglyceridesAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Nov 24, 2020·6 cites·9 claims
- 4398US10722485B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Jul 28, 2020·12 cites·18 claims
- 4498US10292959B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted May 21, 2019·18 cites·16 claims
- 4598US10265290B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Apr 23, 2019·64 cites·8 claims
- 4698US9585859B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Mar 7, 2017·23 cites·12 claims
- 4798US8618166B2Methods of treating mixed dyslipidemiaOSTERLOH IAN·Filed 2012·Granted Dec 31, 2013·35 cites·13 claims
- 4897US10624870B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Apr 21, 2020·5 cites·11 claims
- 4997US10610508B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Granted Apr 7, 2020·11 cites·20 claims
- 5097US9452151B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Sep 27, 2016·17 cites·9 claims
Showing the top 50 of 150 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rene Braeckman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →